The use of sealing hemostat patch (HEMOPATCH
HEMOPATCH®
Hemostasis time
Hemostatic agents
Laparotomic myomectomy
Sealing hemostat patch
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
26
05
2022
accepted:
01
02
2023
medline:
19
4
2023
pubmed:
16
2
2023
entrez:
15
2
2023
Statut:
ppublish
Résumé
Uterine myomas are the most common gynecological disease. In these cases, a myomectomy is performed traditionally laparotomically. However, alternatives have been widely used, including laparoscopic, endoscopic, and robotic surgery. During these techniques, diffuse parenchymatous bleeding remains one of the main intraoperative and postoperative complications and sometimes requires unplanned hysterectomies. Recently, hemostatic agents and sealants have been used to prevent excessive blood loss during surgical repair. We propose a prospective case-control study on the use of a sealing hemostat patch (HEMOPATCH In group A, we achieve faster hemostasis (p < 0.05), than in group B. We report a significantly lower C-reactive protein value on the second and third days after surgery for group A compared to group B. HEMOPATCH
Identifiants
pubmed: 36790464
doi: 10.1007/s00404-023-06957-2
pii: 10.1007/s00404-023-06957-2
doi:
Substances chimiques
Hemostatics
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1521-1528Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman EJM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188(1):100–107. https://doi.org/10.1067/mob.2003.99
doi: 10.1067/mob.2003.99
BhaveChittawar P, Franik S, Pouwer AW, Farquhar EC (2014) Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004638.pub3
doi: 10.1002/14651858.CD004638.pub3
Rivas-López R, Sandoval-García-Travesí FA (2020) Cirugía robótica en ginecología: revisión de la literatura. CIRU 88(1):1332. https://doi.org/10.24875/CIRU.18000636
doi: 10.24875/CIRU.18000636
Parker WH (2007) Uterine myomas: management. Fertil Steril 88(2):255–271. https://doi.org/10.1016/j.fertnstert.2007.06.044
doi: 10.1016/j.fertnstert.2007.06.044
pubmed: 17658523
Friedman JA, Wong JMK, Chaudhari A, Tsai S, Milad MP (2018) Hysteroscopic myomectomy: a comparison of techniques and review of current evidence in the management of abnormal uterine bleeding. Curr Opin Obstet Gynecol 30(4):243–251. https://doi.org/10.1097/GCO.0000000000000475
doi: 10.1097/GCO.0000000000000475
pubmed: 29939852
Milazzo GN, Catalano A, Badia V, Mallozzi M, Caserta D (2017) Myoma and myomectomy: poor evidence concern in pregnancy: myoma and myomectomy in pregnancy. J Obstet Gynaecol Res 43(12):1789–1804. https://doi.org/10.1111/jog.13437
doi: 10.1111/jog.13437
pubmed: 28892210
Hickman LC, Kotlyar A, Shue S, Falcone T (2016) Hemostatic techniques for myomectomy: an evidence-based approach. J Minim Invasive Gynecol 23(4):497–504. https://doi.org/10.1016/j.jmig.2016.01.026
doi: 10.1016/j.jmig.2016.01.026
pubmed: 26855249
Mirowska-Allen KL, Kong KK, Ang WC (2018) Unplanned hysterectomy following myomectomy at a tertiary institution: a case series and review of the literature. J Endometr Pelvic Pain Disord 1(3):151–157. https://doi.org/10.1177/2284026518783664
doi: 10.1177/2284026518783664
Nordentoft T (2015) Sealing of gastrointestinal anastomoses with fibrin glue coated collagen patch. Dan Med J 62(5):B5081
pubmed: 26050838
Oz MC, Rondinone JF, Shargill NS (2003) FloSeal matrix: new generation topical hemostatic sealant. J Card Surg 18(6):486–493. https://doi.org/10.1046/j.0886-0440.2003.00302.x
doi: 10.1046/j.0886-0440.2003.00302.x
pubmed: 14992097
Ayachi A, Bouchahda R, Derouich S, Mkaouer L, Kehila M, Abouda H, Channoufi B, Bouyahia M, Braham M, Zhioua F, Bouchahda H, Mourali M (2018) Accuracy of preoperative real-time dynamic transvaginal ultrasound sliding sign in prediction of pelvic adhesions in women with previous abdominopelvic surgery: prospective, multicenter, double-blind study. Ultrasound Obstet Gynecol 51:253–258
doi: 10.1002/uog.17465
pubmed: 28294441
Seinera P, Arisio R, Decko A, Farina C, Crana F (1997) Laparoscopic myomectomy: indications, surgical technique and complications. Hum Reprod 12(9):1927–1930. https://doi.org/10.1093/humrep/12.9.1927
doi: 10.1093/humrep/12.9.1927
pubmed: 9363708
Kongnyuy EJ, Wiysonge CS (2014) Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005355.pub5
doi: 10.1002/14651858.CD005355.pub5
pubmed: 25125317
pmcid: 9017065
Taylor E, Gomel V (2008) The uterus and fertility. Fertil Steril 89(1):1–16. https://doi.org/10.1016/j.fertnstert.2007.09.069
doi: 10.1016/j.fertnstert.2007.09.069
pubmed: 18155200
Lethaby A, Vollenhoven B, Sowter MC (2001) Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD000547
doi: 10.1002/14651858.CD000547
pubmed: 11405968
Montano N et al (2020) Hemopatch
doi: 10.1016/j.jocn.2020.07.011
pubmed: 33070884
Pisapia A, Crolla E, Saracco M, Saglioccolo A, Dolce P, Molino C (2019) The effectiveness of Hemopatch
doi: 10.1080/17434440.2019.1582328
pubmed: 30757929
Hupe MC, Büttner M, Tabrizi PF, Merseburger AS, Kuczyk MA, Imkamp F (2020) Hemopatch
doi: 10.1007/s12325-020-01584-8
pubmed: 33277680
pmcid: 7889526
Weltert L, D'Aleo S, Chirichilli I, Falco M, Turani F, Bellisario A, et al (2016) Prospective Randomized Clinical Trial of HEMOPATCH Topical Sealant in Cardiac Surgery. Surg Technol Int XXIX:sti29/756
Raga F, Sanz-Cortes M, Bonilla F, Casañ EM, Bonilla-Musoles F (2009) Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril 92(1):356–360. https://doi.org/10.1016/j.fertnstert.2008.04.038
doi: 10.1016/j.fertnstert.2008.04.038
pubmed: 19423098
Angioli R, Plotti F, Ricciardi R, Terranova C, Zullo MA, Damiani P et al (2012) The use of novel hemostatic sealant (Tisseel) in laparoscopic myomectomy: a case-control study. Surg Endosc 26:2046–2053
doi: 10.1007/s00464-012-2154-2
pubmed: 22302534
Lewis KM, Gulle H, Kuntze E (2015) Control of bleeding in surgical procedures: critical appraisal of HEMOPATCH (sealing hemostat). MDER. https://doi.org/10.2147/MDER.S90591
doi: 10.2147/MDER.S90591
Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D (2000) Barrier agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD000475
doi: 10.1002/14651858.CD000475
pubmed: 11034679
Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL (2001) Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Dig Surg 18(4):260–273. https://doi.org/10.1159/000050149
doi: 10.1159/000050149
pubmed: 11528133
Imkamp F, Tolkach Y, Wolters M, Jutzi S, Kramer M, Herrmann T (2015) Initial experiences with the Hemopatch
doi: 10.1007/s00345-014-1404-4
pubmed: 25239500
Olthof PB, Rassam F, van Gulik TM (2018) The use of a NHS-PEG coated, collagen-based sealant in a patient undergoing associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Int J Surg Case Reports 47:7–10. https://doi.org/10.1016/j.ijscr.2018.03.038
doi: 10.1016/j.ijscr.2018.03.038
Tompeck AJ, Gajdhar AUR, Dowling M et al (2020) A comprehensive review of topical hemostatic agents: the good, the bad, and the novel. J Trauma Acute Care Surg 88:e1–e21
doi: 10.1097/TA.0000000000002508
pubmed: 31626024
Gonzalez-Quintero VH, Cruz-Pachano FE (2009) Preventing adhesions in obstetric and gynecologic surgical procedures. Rev Obstet Gynecol 2:38–45
pubmed: 19399293
pmcid: 2672996
Harris JA, Uppal S, Kamdar N et al (2017) A retrospective cohort study of hemostatic agent use during hysterectomy and risk of postoperative complications. Int J Gynaecol Obstet 136:232–237
doi: 10.1002/ijgo.12037
pubmed: 28099744
Anderson CK, Medlin E, Ferriss AF, Sheeder J, Davidson S, Gibbs R et al (2014) Association between gelatin-thrombin matrix use and abscesses in women undergoing pelvic surgery. Obstetrics Gynecol 124(3):589–595
doi: 10.1097/AOG.0000000000000406
Suzuki Y, Vellinga TT, Istre O, Einarsson JI (2010) Small bowel obstruction associated with use of a gelatin-thrombin matrix sealant (FloSeal1) after laparoscopic gynecologic surgery. J Minim Invasive Gynecol 17:641–645
doi: 10.1016/j.jmig.2010.03.024
pubmed: 20728824
Hobday CD, Milam MR, Milam RA et al (2009) Postoperative small bowel obstruction associated with use of hemostatic agents. J Minim Invasive Gynecol 16:224–226
doi: 10.1016/j.jmig.2008.12.002
pubmed: 19249715